Last reviewed · How we verify

NCT03551262: OTSCvsTTS

Over-the-scope Clip Versus Through-the-scope Clip for Endoscopic Hemostasis of High Risk Bleeding Peptic Ulcers

Status unknown NA Last updated 6 May 2023
What this trial tests

NA trial testing OTSC in Bleeding Peptic Ulcer in 88 participants. Status unknown.

Timeline
26 October 2018
Primary endpoint
26 October 2023
26 October 2023

Quick facts

Lead sponsorAzienda USL Modena
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment88
Start date26 October 2018
Primary completion26 October 2023
Estimated completion26 October 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Azienda USL Modena — full company profile →

Who can join

18 and older, any sex, with Bleeding Peptic Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare in a multicenter, prospective, randomized, controlled trial the efficacy and safety of OTSC versus TTS clip for first-line hemostasis of high risk bleeding peptic ulcers

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical efficacy of the over-the-scope clip device: A systematic review.
    Bartell N, Bittner K, Kaul V, Kothari TH, et al · · 2020 · cited 56× · PMID 32655272 · DOI 10.3748/wjg.v26.i24.3495

Verify or expand the search:

Other trials of OTSC

Trials testing the same drug.

Other Azienda USL Modena trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03551262.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing